Form 4: Guardant Health Director Sells Shares Post-Option Exercise

Sentiment:

Insider Transaction Report


Guardant Health Director Manuel Hidalgo Medina exercised stock options and subsequently sold 1,500 shares of common stock on November 7, 2025.

Summary

  • Manuel Hidalgo Medina, a Director of Guardant Health, Inc. (GH), reported transactions on November 7, 2025.
  • Medina exercised 1,000 stock options at an exercise price of $32.55 per share.
  • Following the exercise, Medina sold 1,000 shares of common stock at a price of $95.1651 per share.
  • An additional 500 shares of common stock were sold at $95.2301 per share.
  • After these transactions, Medina directly holds 815 shares of common stock and 16,029 stock options.
  • The stock option exercised was granted on July 17, 2024, with 25% vesting on its one-year anniversary (July 17, 2025) and the remainder vesting monthly over the subsequent three years.

Sentiment

Score: 6

Explanation: The director's profitable exercise and sale of shares is a personal financial event, not directly indicative of company performance or future outlook. It reflects a director monetizing vested equity.

Positives

  • The director realized a substantial profit by exercising stock options at $32.55 and selling shares at an average price of approximately $95.20, indicating strong stock performance at the time of sale.

Negatives

  • The director reduced their direct beneficial ownership of common stock by 1,500 shares through sales.

Stakeholder Impact

  • Shareholders may observe a director reducing their direct common stock holdings, which could be interpreted in various ways, though it's a common practice for insiders to diversify or manage tax liabilities after option exercises.

Key Dates

DateDescription
07/17/2024Stock option granted to Manuel Hidalgo Medina.
07/17/202525% of the granted stock options vested.
11/07/2025Manuel Hidalgo Medina exercised stock options and sold common stock.
11/10/2025Date the Form 4 was signed by attorney-in-fact.
07/17/2034Expiration date of the stock option.

Recommendation

hold

The Form 4 filing details a director's exercise of stock options and subsequent sale of shares, indicating personal financial planning rather than a fundamental shift in company outlook. While the director realized a significant profit, the transaction itself does not provide sufficient new information to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Guardant Health, GH, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.